David F. Hale, Director at Oncternal Therapeutics, Inc. (ONCT), sold 3,669 shares at $4.75 ($17K) on 2021-06-30, disclosed to the SEC on 2021-07-02.
Open-market sale of $17k ONCT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BIOC | SELL | 2020-06-12 | $645 | — | Filing → |
| BIOC | BUY | 2016-10-21 | $200K | — | Filing → |
| BIOC | BUY | 2016-05-05 | $50K | — | Filing → |